Herculite Products, Inc. Completes Capacity Expansion
FEATURED
Less than 1 min.Read

Herculite Products, Inc. Completes Capacity Expansion

Herculite Products Inc., a leading innovator and manufacturer of high-performance and custom fabrics is pleased to announce it has completed the second phase of a multiyear strategic investment into its facilities adding significant additional capacity.

Herculite’s multiyear, multimillion-dollar investment is focused on strengthening their position as a global leader in high-performance reinforced textile composites by increasing production capabilities, expanding manufacturing capacity, and improving organizational efficiency.

The recently completed phase was specifically focused on increasing manufacturing capacity at its Emigsville, Pennsylvania facility. This additional capacity has allowed Herculite to further grow its U.S.-based workforce, achieve record fabric production levels and respond to the historical and unprecedented demand across all Herculite product lines.

The next phases of Herculite’s strategic investment will continue to build on our long history of operational excellence. This strategic investment will significantly advance our organization in its mission to help our customers grow their business by delivering products and services of exceptional value distinguished by their quality and innovation on time.

SourceHerculite Products, Inc.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

0
Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330